文献速递妇科

卵巢恶性肿瘤细胞减灭术同期行肠切除或肠修补与并发症发生率增加相关:一项ACS-NSQIP研究

Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
PubMed 文献 · Gynecol Oncol · 2020-07-06

基于ACS-NSQIP 2006-2017年4965例疑似卵巢恶性肿瘤细胞减灭术的分析,8.3%行肠切开修补、10.9%行结肠切除一期吻合、2.1%行结肠切除造口。肠切除/修补组手术部位感染率显著更高(16.9% vs 5.7%,p<0.0001),校正混杂因素后手术感染 odds 为2.67倍,但30天死亡率未增加。作者建议以前瞻性方式评估降低感染并发症的干预措施。

要点

  • 肠切除/修补组手术部位感染率为16.9%,显著高于对照组的5.7%(p<0.0001)。
  • 校正年龄、BMI、ASA分级等因素后,肠切除/修补患者手术感染 odds 为2.67倍。
  • 肠切除/修补未增加30天死亡率;作者建议以前瞻性方式评估降低感染风险的干预措施。

核心结论

  • 细胞减灭术同期行肠切除/修补的患者手术部位感染风险增加,但30天死亡风险未增加。
  • 作者建议以前瞻性方式评估降低此类患者感染并发症风险的干预措施。

研究设计与样本

  • 基于美国外科医师学会国家手术质量改进项目(ACS-NSQIP)2006-2017年数据集的分析。
  • 纳入4965例因疑似卵巢恶性肿瘤行细胞减灭术的手术记录。
  • 采用单因素方差分析、Kruskal-Wallis H检验和卡方检验比较组间基线特征。
  • 采用多因素logistic回归和线性回归评估术后手术部位感染率及其他30天术后结局。

主要发现

  • 8.3%(413/4965)的细胞减灭术同期行肠切开(小肠或大肠)修补。
  • 10.9%(541/4947)同期行结肠切除一期吻合。
  • 2.1%(104/4965)同期行结肠切除造口。
  • 手术部位感染(包括表浅切口、深部切口、器官间隙感染或伤口裂开)在肠切除/修补组显著更常见(16.9% vs 5.7%,p<0.0001)。
  • 校正年龄、BMI、ASA分级、术前体重下降、低白蛋白血症、NSQIP并发症评分、手术时长和复杂性后,肠切除/修补患者手术感染 odds 为2.67倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Bowel procedures are commonly performed as part of ovarian cancer cytoreduction. The aim of this study was to assess the postoperative complication rates among women with an ovarian malignancy undergoing bowel resection/repair at the time of cytoreductive surgery compared with a control group (cytoreductive surgery without bowel resection or repair). METHODS: Analysis of 4965 cytoreductive surgeries for suspected ovarian malignancies recorded in the American College of Surgeons' National Surgical Quality Improvement Program (NSQIP) datasets (2006-2017) was performed. One-way ANOVA, Kruskal-Wallis H and Chi-squared tests were used to evaluate and compare baseline characteristics between the groups and controls. Postoperative surgical site infection rates and other 30-day post-operative outcomes were assessed with multivariable logistic and linear regressions. RESULTS: 8.3% (413/4965) of cytoreductive procedures had an associated repair of enterotomy (small or large bowel), 10.9% (541/4947) had an associated colectomy with primary anastomosis, and 2.1% (104/4965) had an associated colectomy with colostomy. Surgical site infections (SSI, either superficial incisional, deep incisional, organ space or wound dehiscence) were significantly more prevalent in the bowel resection/repair group (16.9% vs 5.7%, p < 0.0001). The odds of surgical infections were 2.67 times higher in patients who underwent a bowel resection or repair after controlling for age, BMI, ASA status, pre-operative weight loss, hypoalbuminemia, NSQIP morbidity score, length and complexity of surgical procedure. CONCLUSION: Patients undergoing bowel resection/repair at the time of cytoreductive surgery are at increased risk of surgical site infections, without increased risk of 30-day mortality. Interventions to mitigate the risk of infectious complications in these patients should be evaluated in a prospective fashion.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bernard L, Boucher J, Helpman L, et al. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study. Gynecol Oncol. 2020. PMID: 32641239. doi:10.1016/j.ygyno.2020.06.504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。